NCT02057380 2024-11-20A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib TrialAstellas Pharma IncPhase 2 Completed13 enrolled
NCT01497626 2016-02-17Lapatinib and Bortezomib in Patients With Advanced MalignanciesGeorgetown UniversityPhase 1 Terminated15 enrolled